Bone marrow transplantation for therapy-related myelodysplasia: Comparison with primary myelodysplasia

Bone Marrow Transplantation

Volumn 20, Issue 9, 1997, Pages 737-743

  Ballen, K K ^a   Gilliland, D G ^b   Guinan, E C ^b   Hsieh, C C ^a   Parsons, S K ^b   Rimm, I J ^b   Ferrara, J L M ^b   Bierer, B E ^b   Weinstein, H J ^b   Antin, J H ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Myelodysplasia

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PREDNISONE; PROCARBAZINE; TACROLIMUS; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBROSIS; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOCYTE DEPLETION; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; RADIATION INJURY; RELAPSE; SURVIVAL; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0030670146     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700971     Document Type: Article

References (53)

1. Buzaid AC, Garewal HS, Greenberg BR. Management of myelodysplastic syndromes. Am J Med 1986; 80: 1149-1157.
2. Cheson BD. The myelodysplastic syndromes: current approaches to therapy. Ann Intern Med 1990; 112: 932-941.
3. Fialkow PJ, Singer JW, Raskind WH et al. Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. New Engl J Med 1987; 317: 468-473.
4. Kantarjian HM, Keating MJ. Therapy-related leukemia and myelodysplastic syndrome. Semin Oncol 1987; 14: 435-443.
5. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 1992; 19: 47-84.
6. Levine EG, Bloomfield CD. Secondary myelodysplastic syndromes and leukemias. Clin Hematol 1986; 15: 1037-1078.
7. Michels SD, McKenna RW, Arthur DC et al. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 1986; 65: 1364-1372.
8. Roman-Unfer S, Bitran JD, Hanauer S et al. Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. Bone Marrow Transplant 1995; 16: 163-168.
9. Miller JS, Arthur DC, Litz CE et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83: 3780-3786.
10. Stone RM. Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress? Blood 1994; 83: 3437-3440.
11. Kantarjian HM, Estey EH, Keating MJ. Treatment of therapy-related leukemia and myelodysplastic syndrome. Hematol/Oncol Clin N Am 1993; 7: 81-106.
12. Le Beau MM, Albain KS, Larson RA et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4: 325-345.
13. Pedersen-Bjergaard J, Philip P, Larsen SO et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant disease in the Copenhagen series. Leukemia 1993; 7: 1975-1986.
14. De Witte T. New treatment approaches for myelodysplastic syndromes and secondary leukemias. Ann Oncol 1994; 5: 401-408.
15. Cheson BD. Chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Semin Oncol 1992; 19: 85-94.
16. De Witte T, Blacklock HA, Prentice HG et al. Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's disease. Cancer 1984; 53: 1507-1508.
17. Cheson BD, Jasperse DM, Simon R et al. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J Clin Oncol 1986; 4: 1857-1864.
18. Chitambar CR, Libnoch JA, Matthaeus WG. Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes. Am J Hematol 1991; 37: 100-104.
19. Clark RE, Ismail AD, Jacobs A et al. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome. Br J Haematol 1987; 66: 77-83.
20. Ganser A, Lindermann A, Seipelt G et al. Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 1990; 75: 666-676.
21. Priesler HD, Raza A, Barcos M et al. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia. J Clin Oncol 1987; 5: 75-82.
22. Gradishar WJ, Le Beau MM, O'Laughlin R et al. Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia. Blood 1992; 80: 2463-2470.
23. O'Donnell JR, Nademanee AP, Snyder DS et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol 1987; 5: 1822-1826.
24. Guinan EC, Tarbell NJ, Tantravahi R et al. Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73: 619-622.
25. Belanger R, Gyger M, Perreault C et al. Bone marrow transplantation for myelodysplastic syndromes. Br J Haematol 1988; 69: 29-33.
26. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodys-plastic syndrome. Blood 1993; 82: 677-681.
27. Longmore G, Guinan EC, Weinstein HJ et al. Bone marrow transplantation for myelodysplasia and secondary acute non-lymphocytic leukemia. J Clin Oncol 1990; 8: 1707-1714.
28. Bunin NJ, Casper JT, Chitambar C et al. Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. J Clin Oncol 1988; 5: 1851-1855.
29. De Witte T, Zwaan F, Hermans J et al. Allogeneic bone marrow transplantation for secondary leukemia and myelodysplastic syndrome; a survey by the leukemia working party of the European Bone Marrow Transplantation Group. Br J Haematol 1990; 74: 151-155.
30. Geller RB, Vogelsang GB, Wingard JR et al. Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease. J Clin Oncol 1988; 6: 1558-1561.
31. Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the acute leukemias: French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451-458.
32. Wheeler C, Antin JH, Churchill WH et al. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study. J Clin Oncol 1990; 8: 648-656.
33. Mitus AJ, Miller KB, Schenkein DP et al. Improved survival for patients with acute myelogenous leukemia. J Clin Oncol 1995; 3: 560-569.
34. Antin JH, Bierer BE, Smith BR et al. Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood 1991; 78: 2139-2149.
35. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
36. Kaplan G, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
37. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
38. Greenberg P, Fenaux P, Morel P et al. International workshop consensus risk analysis system for myelodysplastic syndromes (MDS). Blood 1995; 86 (Suppl. 1): 270a.
39. Sargur M, Buckner CD, Appelbaum FR et al. Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease. J Clin Oncol 1987; 5: 731-734.
40. Sutton L, Leblond V, Le Maignan C. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplant 1991; 7 (Suppl. 2): 39.
41. Ballen KK, Antin JH. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes. Hematol/Oncol Clin N Am 1993; 7: 477-491.
42. Anderson JE, Appelbaum FR, Schoch G et al. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. J Clin Oncol 1996; 14: 220-226.
43. Fung HC, Shepherd JD, Nantel SH et al. Allogeneic bone marrow transplantation for adults with primary myelodysplastic syndrome (MDS): evaluation of prognostic factors. Blood 1996: 88 (Suppl. 1): 480a (Abstr. 1909).
44. O'Reilly RJ, Collins NH, Kernan NA et al. Transplantation of marrow depleted of T cells by soybean lectin agglutination and E rosette depletion: major histocompatibility complexrelated graft resistance in leukemic transplant recipients. Transplant Proc 1985; 17: 455-459.
45. Soll E, Massumoto C, Clift RA et al. Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment. Blood 1995; 86: 4667-4673.
46. Schultz AB, Geller RB, Hillyer CD. The role of bone marrow transplantation in the treatment of myelodysplastic syndromes. J Hematother 1995; 4: 323-324.
47. Anderson JE, Appelbaum FR, Schoch G et al. Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. Blood 1996; 87: 51-58.
48. O'Donnell MR, Long GD, Parker PM et al. Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia. J Clin Oncol 1995; 13: 2973-2979.
49. Nevill TJ, Shepherd JD, Reece DE et al. Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplant 1992; 10: 445-450.
50. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. New Engl J Med 1993; 328: 593-602.
51. Thomas ED, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861-865.
52. Thomas ED, Clift RA, Fefer A et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104: 155-161.
53. De Witte T, Hermans J, Van Viezen A et al. Prognostic variables in bone marrow transplantation for secondary leukemia and myelodysplastic syndromes: a survey of the Working Party of Leukemia. Bone Marrow Transplant 1991; 8 (Suppl. 1 ): 40.